A Population Pharmacokinetics Study of Venetoclax Concomitant with Voriconazole in Patients with Hematologic Malignancies
Co-administration of voriconazole contributed to elevated venetoclax exposure. These potential DDIs suggest the need for therapeutic drug monitoring of venetoclax.
Authors
- Jing Yang (ORCID: https://orcid.org/0000-0002-2113-6578)
- Peile Wang (ORCID: https://orcid.org/0000-0002-3264-4092)
- Haoran Wang (ORCID: https://orcid.org/0009-0006-1408-3363)
- Dongmei Liu (ORCID: https://orcid.org/0000-0003-1645-3998)
- Weijie Cao (ORCID: https://orcid.org/0000-0001-6977-7406)
- Han Xing
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/dddt.s514173
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40